Quoin pharmaceuticals provides corporate update and announces third quarter 2022 financial results

Ashburn, va., nov. 10, 2022 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today provides a business update and announces financial results for the third quarter, ended september 30, 2022.
QNRX Ratings Summary
QNRX Quant Ranking